Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MULTIPLE SCLEROSIS Latest News

NOV 08, 2013 - MedPage Today

A Must Read - Share

FDA Reviewers Slam Lemtrada Efficacy, Safety

(MedPage Today) -- SILVER SPRING, Md. -- FDA staff reviewing the marketing application for alemtuzumab (Lemtrada) for multiple sclerosis questioned both the product's safety and its efficacy.

Tags: FDA Reviewers Slam Lemtrada Efficacy, Safety,  Multiple Sclerosis Latest News